[논문]Clinical Characteristics of Dialysis Related Sclerosing Encapsulating Peritonitis: Multi-center Experience in Korea

Kim, Beom Seok; Choi, Hoon Young; Ryu, Dong-Ryeol; Yoo, Tae Hyun; Park, Hyeong Cheon; Kang, Shin Wook; Choi, Kyu Hun; Ha, Sung Kyu; Han, Dae Suk; Lee, Ho Yung

doi:10.3349/ymj.2005.46.1.104

Clinical Characteristics of Dialysis Related Sclerosing Encapsulating Peritonitis: Multi-center Experience in Korea 원문보기

Yonsei medical journal, v.46 no.1, 2005년, pp.104 - 111

Kim, Beom Seok (Division of Nephrology, Department of Internal Medicine, College of Medicine, Institute of Kidney Disease, Yonsei University, Seoul, Korea.) , Choi, Hoon Young (Division of Nephrology, Department of Internal Medicine, College of Medicine, Institute of Kidney Disease, Yonsei University, Seoul, Korea.) , Ryu, Dong-Ryeol (Division of Nephrology, Department of Internal Medicine, College of Medicine, Institute of Kidney Disease, Yonsei University, Seoul, Korea.) , Yoo, Tae Hyun (Division of Nephrology, Department of Internal Medicine, College of Medicine, Institute of Kidney Disease, Yonsei University, Seoul, Korea.) , Park, Hyeong Cheon (Division of Nephrology, Department of Internal Medicine, College of Medicine, Institute of Kidney Disease, Yonsei University, Seoul, Korea.) , Kang, Shin Wook (Division of Nephrology, Department of Internal Medicine, College of Medicine, Institute of Kidney Disease, Yonsei University, Seoul, Korea.) , Choi, Kyu Hun (Division of Nephrology, Department of Internal Medicine, College of Medicine, Institute of Kidney Disease, Yonsei University, Seoul, Korea.) , Ha, Sung Kyu (Divisi) , Han, Dae Suk , Lee, Ho Yung

Abstract ▼ AI-Helper

Sclerosing encapsulating peritonitis (SEP) is a rare but serious complication in patients with continuous ambulatory peritoneal dialysis (CAPD), and is characterized by a progressive, intra-abdominal, inflammatory process resulting in the formation of sheets of new fibrous tissue, which cover, bind, and constrict the viscera, thereby compromising the motility of the bowel. No satisfactory estimate is available on the comparative incidence of dialysis related SEP and the pathogenesis of SEP still remains uncertain. Although recent therapeutic approaches have reported varying degrees of success, an efficient measure to detect, at an early stage, patients at risk for SEP would be beneficial and a standardized treatment regimen to prevent the illness is urgently needed. This study aimed to evaluate the clinical features of SEP and to identify the possible risk factors for the development of SEP in CAPD patients. We retrospectively reviewed by questionnaire SEP cases among CAPD patients from 7 university hospital dialysis centers in Korea, including Yonsei University, Ajou University, Catholic University, Inha University, Kyungpook University, Seoul National University and Soonchunhyang University, from January 1981 to December 2002. Out of a total of 4,290 CAPD patients in these centers, 34 cases developed SEP with an overall prevalence of 0.79%. The male to female ratio was 17:17. The median age of these patients was 44.5 years (range 19 - 66). The median duration of CAPD before SEP was 64 months (9 - 144) and 68% of patients (23/34) had been on CAPD for more than 4 years. Peritonitis (including two fungal cases) was the main cause of catheter removal in SEP (27 cases, 79%). Seventy-five percent of the cases (15/20) were administered β-blocker for a mean duration of 85 months (26 - 130). Among 10 cases with available peritoneal equilibration test (PET) data, 8 showed high transporter characteristics, and the remaining 2 were high average. Eighteen cases were diagnosed by clinical and radiologic methods, and 16 were surgically diagnosed. Eleven cases were surgically treated and the others were treated conservatively with intermittent total parenteral nutrition (TPN). The overall mortality rate was 24%. SEP is a serious, life threatening complication of CAPD. Most cases had a PD duration of more than 4 years, a history of severe peritonitis, and high transporter characteristics in PET. Therefore, to reduce the incidence of SEP, careful monitoring and treatment, including early catheter removal in patients with severe peritonitis, should be considered for long-term CAPD patients with the above characteristics.

주제어

참고문헌 (39)

1 Gandhi VC Humayun HM Ing TS Daugirdas JT Jablokow VR Iwatsuki S Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients Arch Intern Med 1980 140 1201 1203 7406618

상세보기
2 Oules R Challah S Brunner FP Case-control study to determine the cause of sclerosing peritoneal disease Nephrol Dial Transplant 1988 3 66 69 3132642

상세보기
3 Dobbie JW Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis Perit Dial Int 1992 12 14 27 1347465
4 Cox SV Lai J Suranyi M Walker N Sclerosing peritonitis with gross peritoneal calcification: a case report Am J Kidney Dis 1992 20 637 642 1462995

상세보기
5 Twardowski ZJ Clinical value of standardized equilibration tests in CAPD patients Blood Purif 1989 7 95 108 2663040

상세보기
6 Trivedi H Khanna R Lo WK Prowant BF Nolph KD Reproducibility of the peritoneal equilibration test in CAPD patients Asaio J 1994 40 M892 M895 8555641

상세보기
7 Marichal JF Faller B Brignon P Wagner D Straub P Progressive calcifying peritonitis: a new complication of CAPD? Report of two cases Nephron 1987 45 229 232 3574572

상세보기
8 Nomoto Y Kawaguchi Y Kubo H Hirano H Sakai S Kurokawa K Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group Am J Kidney Dis 1996 28 420 427 8804242

상세보기
9 Rigby RJ Hawley CM Sclerosing peritonitis: the experience in Australia Nephrol Dial Transplant 1998 13 154 159 9481732

상세보기
10 Afthentopoulos IE Passadakis P Oreopoulos DG Bargman J Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature Adv Ren Replace Ther 1998 5 157 167 9686626
11 Garosi G Di Paolo N Peritoneal sclerosis: one or two nosological entities? Semin Dial 2000 13 297 308 11014691
12 Oreopoulos DG Khanna R Wu G Sclerosing obstructive peritonitis after CAPD Lancet 1983 2 409 6135907
13 Di Paolo N Garosi G Peritoneal sclerosis J Nephrol 1999 12 347 361 10626824
14 Holland P Sclerosing encapsulating peritonitis in chronic ambulatory peritoneal dialysis Clin Radiol 1990 41 19 23 2404649

상세보기
15 Ing TS Daugirdas JT Gandhi VC Peritoneal sclerosis in peritoneal dialysis patients Am J Nephrol 1984 4 173 176 6742010

상세보기
16 Slingeneyer A Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis Contrib Nephrol 1987 57 239 247 2890497

상세보기
17 Selgas R Bajo MA Del Peso G Jimenez C Preserving the peritoneal dialysis membrane in long-term peritoneal dialysis patients Semin Dial 1995 8 326 332
18 Krediet RT Advances in peritoneal dialysis: towards improved efficacy and safety Blood Purif 1998 16 1 14 9513757

상세보기
19 Marigold JH Pounder RE Pemberton J Thompson RP Propranolol, oxprenolol, and sclerosing peritonitis Br Med J 1982 284 870 6802333

상세보기
20 Myllarniemi H Leppaniemi A Peritoneal fibrosis due to practolol. Scanning electron microscopical and histological observations Acta Chir Scand 1981 147 137 142 7324743

상세보기
21 Nicholls JT Rutty DA Sclerosing peritonitis with short-term propranolol therapy Arch Intern Med 1980 140 1124 1125 6446892

상세보기
22 Eisenberg ES Alpert BE Weiss RA Mittman N Soeiro R Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis Am J Med 1983 75 349 352 6881189

상세보기
23 Flanigan M Anderson D Freeman RM Peritoneal dialysis complicated by fungal peritonitis and peritoneal fibrosis Am J Med 1984 76 A113 A125 6720720

상세보기
24 Tzamaloukas AH Peritonitis in peritoneal dialysis patients: an overview Adv Ren Replace Ther 1996 3 232 236 8827203
25 Chew CG Clarkson AR Faull RJ Relapsing CAPD peritonitis with rapid peritoneal sclerosis due to Haemophilus influenzae Nephrol Dial Transplant 1997 12 821 822 9141024

상세보기
26 Verger C Brunschvicg O Le Charpentier Y Lavergne A Vantelon J Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis Proc EDTA 1981 18 199 205
27 Baron MA Structure of the intestinal peritoneum in man Am J Anat 1941 69 439 496

상세보기
28 Jorres A Gahl GM Frei U Peritoneal dialysis fluid biocompatibility: Does it really matter? Kidney Int Suppl 1994 48 S79 S86 7700046
29 Junor BJ McMillan MA Immunosuppression in sclerosing peritonitis Adv Perit Dial 1993 9 187 189 8105920

상세보기
30 Charney DI Gouge SF Chemical peritonitis secondary to intraperitoneal vancomycin Am J Kidney Dis 1991 17 76 79 1986571

상세보기
31 Campbell S Clarke P Hawley C Wigan M Kerlin P Butler J Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features Am J Kidney Dis 1994 24 819 825 7977325

상세보기
32 Kawaguchi Y Kawanishi H Mujais S Topley N Oreopoulos DG Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis Perit Dial Int 2000 20 Suppl 4 S43 S55 11098928
33 Perez-Fontan FJ Soler R Sanchez J Iglesias P Sanjurjo P Ruiz J Retractile mesenteritis involving the colon: barium enema, sonographic, and CT findings AJR Am J Roentgenol 1986 147 937 940 3532734
34 Celicout B Levard H Hay J Msika S Fingerhut A Pelissier E French Associations for Surgical Research Sclerosing encapsulating peritonitis: early and late results of surgical management in 32 cases Dig Surg 1998 15 697 702 9845640

상세보기
35 Genereau T Bellin MF Wechsler B Le TH Bellanger J Grellet J Demonstration of efficacy of combining corticosteroids and colchicine in two patients with idiopathic sclerosing mesenteritis Dig Dis Sci 1996 41 684 688 8674388

상세보기
36 Eltringham WK Espiner HJ Windsor CW Griffiths DA Davies JD Baddeley H Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management Br J Surg 1977 64 229 235 856375

상세보기
37 Assalia A Schein M Hashmonai M Problems in the surgical management of sclerosing encapsulating peritonitis Isr J Med Sci 1993 29 686 688 8270396
38 Jackson BT Surgical treatment of sclerosing peritonitis caused by practolol Br J Surg 1977 64 255 257 851701

상세보기
39 Kittur DS Korpe SW Raytch RE Smith GW Surgical aspects of sclerosing encapsulating peritonitis Arch Surg 1990 125 1626 1628 2244819

상세보기

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Clinical Characteristics of Dialysis Related Sclerosing Encapsulating Peritonitis: Multi-center Experience in Korea 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (39)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트